Yellow Pentylone BK EBDP Molly Big Crystal CAS 1112937-64-0 Formula C11H13NO3
Buy Yellow Pentylone BK EBDP , also known as 3,4-methylenedioxy-N-ethylcathinone (MDEC, βk-MDEA), is classified as an , and of theIt is the of (“Eve”). Ethylone has only a short history of human use and is reported to be less potent than its relative In the United States, it began to be found in cathinone products
MDMB-CHIMICA (also incorrectly known as MMB-CHMINACA) is based that is a potent of that and has been sold online While MDMB-CHIMICA was initially sold under the name “MMB-CHMINACA”, the compound corresponding to this code name (i.e. the isopropyl instead of t-butyl analog of has been identified on the designer drug market in 2015 as amb-china
5F-AB-PINACA is that is derived from a series of compounds originally developed in 2009 as medication and has been sold online
5F-AB-PINACA has been reported to be a potent of the bandwidth values of 0.48 nM and 2.6 nM respectively. Its metabolism has been described in the literature.
Methaqualone, sold under the brand name Quaalude in the US and Mandrax in the UK and South Africa, is medication. It is a member of the e class.Buy Yellow Pentylone BK EBDP
The sedative-hypnotic activity of methaqualone was first noted by researchers in the 1950s. In 1962, methaqualone was patented in the US by Wallace and Tiernan. Its use peaked in the early 1970s as a or the treatment
Etaqualone (Aolan, Athinazone, Ethinazone is a class and is an analog of that was developed in the 1960s and marketed mainly in France and some other European countries. It has and properties resulting from its agonist activity at the β-subtype of the, and was used for the treatment of
25I-NBOMe (2C-I-NBOMe, Cimbi-5, also shortened to “25I“, and colloquially referred to as “N-bomb“ is a and derivative of the psychedelicIt was discovered in 2003 by chemist Ralf Heim at the who published his findings in his PhD dissertation. The compound was subsequently investigated by a team at led by
6–MAPB (1-(benzofuran-6-yl)-N-methylpropan-2-amine) is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA. It is not known
5-MAPB (1-(benzofuran-5-yl)-N-methylpropan-2-amine) is similar to on its structure and effects.
Oxycodone has been in clinical use since 1916, and it is used for managing moderate to moderately severe acute or chronic It has been found to improve for those with many types of pain.[ Experts are divided regarding use for non-cancer-related chronic pain, as most opioids have great potential for dependence and may also create
Diclazepam (Ro5-3448), also known as chlorodiazepam and 2′-chloro-diazepam, is a . It was first synthesized by and his team at Hoffman-La Roche in 1960.It is not currently approved for use as a medication, but rather sold as an Efficacy and safety have not been tested in humans.
Ergotamine is an and part of the family o; it is structurally and biochemically closely
related to It possesses structural similarity to several and has as a
It is used for treatment of acute attacks (sometimes in combination with Medicinal usage of ergot fungus began in the 16th century to induce yet dosage uncertainties discouraged the use. It has been used to prevent (bleeding after childbirth). It was first isolated from the ergot fungus and marketed as Gynergen in 1921
N-Ethylhexedrone (also known as α-ethylaminocaprophenone, N-ethylnorhexedrone, hexenand NEH) is of the classN-Ethylhexedrone was first mentioned in a series of patents by in the 1960s which lead to the development of the better known drug (MDPV). Since the mid-2010s, N-ethylhexedrone has been sold online
Fentanyl provides some of the effects typical of other opioids through its agonism the. Its strong potency in relation to that of morphine is largely due to its higher the Because of this, it can more easily penetrate the
BROMADOLINE is the same effect as u-47700
Alprazolam is mostly used to treat and The MDMA label advises that the physician should periodically reassess the usefulness of the drug. Alprazolam may also be indicated for the treatment of generalized anxiety disorder, as well as for the treatment of anxiety conditions with co-morbid depression. Alprazolam is also often prescribed with instances co-morbid sleep deficits.